These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 6653756

  • 1. [Mechanism of the vasodilator action of kavinton on the cerebral vessels].
    Plotnikov MB, Kotov AN.
    Farmakol Toksikol; 1983; 46(6):36-9. PubMed ID: 6653756
    [Abstract] [Full Text] [Related]

  • 2. [Electrophysiological analysis of the action of kavinton on the smooth muscles].
    Gurkovskaia AV, Gokina NI, Buryĭ VA, Shuba MF.
    Biull Eksp Biol Med; 1987 Jan; 103(1):68-71. PubMed ID: 3801654
    [Abstract] [Full Text] [Related]

  • 3. Calcium antagonistic vasodilator mechanisms of brovincamine fumarate studied in canine cerebral artery.
    Tanaka Y, Morimoto K, Ishii K, Nakayama K.
    Arzneimittelforschung; 1994 Jul; 44(7):803-8. PubMed ID: 7945512
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Mechanism of action of vinpocetine].
    Kiss B, Kárpáti E.
    Acta Pharm Hung; 1996 Sep; 66(5):213-24. PubMed ID: 9082841
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE.
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of endothelin-1 on the myogenic contraction of canine cerebral artery in response to quick stretch.
    Tanaka Y, Shigenobu K, Nakayama K.
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):95-101. PubMed ID: 11458989
    [Abstract] [Full Text] [Related]

  • 14. [The neurotropic action of kavinton].
    Trepakov VV, Buldakova SL, Latanov AV, Saakian SA, Iashchenko EA.
    Farmakol Toksikol; 1987 Jul; 50(4):29-33. PubMed ID: 3499349
    [Abstract] [Full Text] [Related]

  • 15. Effects of VA-045, a novel apovincaminic acid derivative, on rabbit basilar artery.
    Yamada S, Okuyama S, Kamata K.
    Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):269-76. PubMed ID: 8747794
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Studying cGMP-dependent mechanisms of vinpocetine effect on smooth muscle cells].
    Kovalev IV, Baskakov MB, Popov AG, Kilin AA, Minochenko IL, Borodin IuL, Panov AA, Afinogenova IaD, Kapilevich LV, Medvedev MA.
    Eksp Klin Farmakol; 2003 Nov; 66(4):25-8. PubMed ID: 14558347
    [Abstract] [Full Text] [Related]

  • 18. [Effect of cavinton on the indices of carbohydrate metabolism in the blood vessel wall].
    Turkova LA.
    Farmakol Toksikol; 1988 Nov; 51(2):62-3. PubMed ID: 2454202
    [Abstract] [Full Text] [Related]

  • 19. [Mechanisms of activation of phasic and tonic contraction of cerebral artery smooth muscle].
    Gokina NI, Gurkovskaia AV, Shuba MF.
    Fiziol Zh (1978); 1983 Nov; 29(6):684-90. PubMed ID: 6653811
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries.
    Birk S, Edvinsson L, Olesen J, Kruuse C.
    Eur J Pharmacol; 2004 Apr 05; 489(1-2):93-100. PubMed ID: 15063160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.